You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 5, May 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ocular/ Adnexal Tumors
 •Radiologic Imaging
 •Alert me on articles by topic

Ultrasound Biomicroscopy in Management of Malignant Iris Melanoma

Arch Ophthalmol. 2003;121:725-727.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

High-frequency ultrasound biomicroscopy (UBM) provides high-resolution cross-sectional images of anterior segment structures. Few published reports have correlated abnormal UBM images with histopathologic findings. A recent report by Marigo et al1 compared ultrasound images of iris and ciliary body melanomas with their histopathologic features. They found that UBM accurately defined the tumor shape andthe extent of local invasion. There is histopathologic evidence that iris melanomas can spread through unguarded (Scheie procedure2 and iridencleisis3) and guarded (trabeculectomy4) glaucoma procedures. We show that UBM can accurately determine the depth of tissue penetration by an iris melanoma into a trabeculectomy site by correlating the clinical images with the histopathologic features after enucleation.

Report of a Case

In January 1995, a 59-year-old white woman was evaluated for rising intraocular pressure in the left eye. The patient had been prescribed timolol maleate, pilocarpine, apraclonidine hydrochloride, andacetazolamide by the referring ophthalmologist. She had a history of a pigmented iris . . . [Full Text of this Article]


Pathologic Description

Comment
Corresponding author and reprints: Dennis M. Robertson, MD, Department of Ophthalmology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (e-mail: robertson.dennis@mayo.edu).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Expression of vascular endothelial growth factor in iris melanoma.
Lee et al.
Arch Ophthalmol 2006;124:1349-1350.
FULL TEXT  

Ultrasound biomicroscopy: role in diagnosis and management in 130 consecutive patients evaluated for anterior segment tumours
Conway et al.
Br. J. Ophthalmol. 2005;89:950-955.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.